ONCAlert | AstraZeneca: Pioneers in Ovarian Cancer

The Future of Biomarkers in Prostate Cancer

Mark Stein, MD
Published Online:10:35 AM, Tue November 22, 2016

Mark Stein, MD, medical oncologist, Rutgers Cancer Institute of New Jersey, discusses the future of biomarkers in prostate cancer.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.